Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein

Cancer Research

Volumn 60, Issue 1, 2000, Pages 47-50

  Rabindran, Sridhar K ^a   Ross, Douglas D ^b,c,d   Doyle, L Austin ^b,c   Yang, Weidong ^b   Greenberger, Lee M ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FUMITREMORGIN C; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; DRUG EFFICACY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INDOLES; NEOPLASM PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033966957     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Young, R. C. Drug resistance: the clinical problem. In: R. F. Ozols (ed.), Drug Resistance in Cancer Therapy, pp. 1-12. Boston: Kluwer Academic Press, 1989.
2. Greenberger, L. M., Cohen, D., and Horwitz, S. B. In vitro models of multiple drug resistance. In: L. J. Goldstein and R. F. Ozols (eds.), Anticancer Drug Resistance, pp. 69-106. Norwell, MA: Kluwer Academic Publishers, 1994.
3. Allikmets, R., Gerrard, B., Hutchinson A., and Dean, M. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Human Mol. Genet., 5: 1649-1655, 1996.
4. Gros, P., Neriah, Y. B., Croop, J. M., and Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.), 232: 728-731, 1986.
5. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I. Expression of full-length cDNA for the human "MDRI" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84: 3004-3008, 1987.
6. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. C., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases in resistance to natural products. Cancer Res., 54: 357-361, 1994.
7. Zaman, G. J. R., Flens, M. J., van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., and Borst, P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA, 91: 8822-8826, 1994.
8. Breuninger, L. M., Paul, S., Gaughan, K., Miki, T., Chan, A., Aaronson, S. A., and Kruh, G. D. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res., 55: 5342-5347, 1995.
9. Kawabe, T., Chen, Z. S., Wada, M., Uchiumi, T., Ono, M., Akiyama, S., and Kuwano, M. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett., 456: 327-331, 1999.
10. Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M., Smith, A. J., Jansen, G., Peters, G. I., Ponne, N., Scheper, R. J., Elferink, R. P., Baas, F., and Borst, P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA, 96: 6914-6919, 1999.
11. Miyake K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T., and Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transporters. Cancer Res., 59: 8-13, 1999.
12. Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V., and Dean, M. A placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58: 5337-5339, 1998.
13. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA. 95: 15665-15670, 1998.
14. Sikic, B. I. Pharmacologic approaches to reversing multidrug resistance. Semin. Hematol., 34: 40-47, 1997.
15. Lautier, D., Canitrot, Y., Deeley, R. G., and Cole, S. P. C. Multidrug resistance mediated by the multidrug resistance protein gene. Biochem. Pharmacol., 52: 967-977, 1996.
16. Atadja, P., Watanabe, T., Xu, H., and Cohen, D. PSC-833 a frontier in modulation of P-glycoprotein mediated multidrug resistance. Cancer Metastasis Rev., 17: 163-168, 1998.
17. Rabindran S. K., He, H., Singh, M., Brown, E., Collins, K. I., Annable, T., and Greenberger, L. M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res., 58: 5850-5858, 1998.
18. Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., and Doyle, L. A. Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cells. J. Natl. Cancer Inst., 91: 429-433, 1999.
19. Hazlehurst, L. A., Foley, N. E., Gleason-Guzman, M. C., Hacker, M. P., Cress, A. E., Greenberger, L. W., De Jong, M. C., and Dalton, W. S. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res., 59: 1021-1028, 1999.
20. Chen, Y-N., Mickley, L. A., Schwartz, A. M., Acton, E., Hwang, J., and Fojo, A. T. Characterization of Adriamycin-resistanl human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J. Biol. Chem., 265: 10073-10080, 1990.